Diversified Healthcare Trust (DHC) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
DHC Revenue Growth
Revenue Breakdown (FY 2025)
DHC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
DHC Revenue Analysis (2014–2025)
As of May 8, 2026, Diversified Healthcare Trust (DHC) generated trailing twelve-month (TTM) revenue of $1.52 billion, reflecting moderate decline in growth of -5.3% year-over-year. The most recent quarter (Q1 2026) recorded $366.5 million in revenue, down 3.5% sequentially.
Looking at the longer-term picture, DHC's 5-year compound annual growth rate (CAGR) stands at -1.2%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $1.63 billion in 2020.
Revenue diversification analysis shows DHC's business is primarily driven by Resident Fees And Services (85%), and Rental Income (15%). With over half of revenue concentrated in Resident Fees And Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Real Estate sector peers including VTR (+20.7% YoY), WELL (+38.3% YoY), and OHI (+14.2% YoY), DHC has underperformed the peer group in terms of revenue growth. Compare DHC vs VTR →
DHC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DHCCurrent | $1.5B | -5.3% | -1.2% | -2.6% | |
 VTR | $5.8B | +20.7% | +9.0% | 14.2% | |
 WELL | $10.7B | +38.3% | +18.4% | 3.3% | |
 OHI | $1.2B | +14.2% | +6.1% | 62.6% | |
 SBRA | $775M | +12.9% | +5.3% | 34.1% | |
 LTC | $263M | +49.0% | +10.5% | 48.2% |
DHC Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.54B | +2.8% | $-245,333,000 | -16.0% | $-39,268,000 | -2.6% |
| 2024 | $1.50B | +6.0% | $256.4M | 17.1% | $229.9M | 15.4% |
| 2023 | $1.41B | +9.9% | $225.3M | 16.0% | $199.2M | 14.1% |
| 2022 | $1.28B | -7.2% | $174.5M | 13.6% | $-91,219,000 | -7.1% |
| 2021 | $1.38B | -15.2% | $291.4M | 21.1% | $-13,818,000 | -1.0% |
| 2020 | $1.63B | +56.9% | $394.9M | 24.2% | $364.3M | 22.3% |
| 2019 | $1.04B | -6.9% | $538.0M | 51.7% | $501.0M | 48.2% |
| 2018 | $1.12B | +3.9% | $665.4M | 59.6% | $579.5M | 51.9% |
| 2017 | $1.07B | +1.6% | $660.8M | 61.5% | $557.1M | 51.8% |
| 2016 | $1.06B | +5.9% | $656.1M | 62.0% | $609.6M | 57.6% |
See DHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DHC vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonDHC — Frequently Asked Questions
Quick answers to the most common questions about buying DHC stock.
Is DHC's revenue growth accelerating or slowing?
DHC revenue declined -5.3% year-over-year, contrasting with the 5-year CAGR of -1.2%. TTM revenue fell to $1.5B. This reverses the prior growth trend.
What is DHC's long-term revenue growth rate?
Diversified Healthcare Trust's 5-year revenue CAGR of -1.2% reflects the variable expansion pattern. Current YoY growth of -5.3% is below this long-term average.
How is DHC's revenue distributed by segment?
DHC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.